Therapeutic and prophylactic efficacy of milbemycin oxime (interceptor) against Thelazia callipaeda in naturally exposed dogs
Abstract
Two trials were conducted to evaluate the therapeutic and prophylactic activity of milbemycin oxime (Interceptor, Novartis Animal Health) against the eye-worm Thelazia callipaeda (Spirurida, Thelaziidae) infection. In Trial 1, the therapeutic efficacy of milbemycin oxime was evaluated in 55 naturally infected dogs treated with min. 0.5mg/kg milbemycin oxime. The dogs were clinically examined for the presence of eyeworms before and again 7 days after treatment. Dogs still positive were given a second treatment and re-checked again a week later. Forty-eight of the 55 dogs tested negative 1 week after treatment (87.3% reduction of infection rate). Following the second treatment 6 of these 7 dogs tested negative 1 week later resulting, after two treatments, in a reduction of infection rate of 98.2%. In Trial 2, the prophylactic efficacy of milbemycin oxime was evaluated in 60 uninfected dogs. Thirty dogs were treated with milbemycin oxime monthly from June to November with the recommended dose rate for the prevention of heartworm disease (> or =0.5mg/kg), 30 dogs served as untreated controls. At the end of the trail 1 dog in the treated group and 10 dogs in the control group became infected during the trial. The incidence of infection differed significantly between treated and control dogs (p=0.0056). The efficacy of the prophylactic use of a monthly treatment with milbemycin oxime showed 90% efficacy in reducing T. callipaeda infection rate.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
A monthly treatment with milbemycin oxime provides some seasonal protection against T. callipaeda infestation in dogs from an endemic area of northern Italy.
“The administration of an injectable sustained-release formulation of moxidectin and of a monthly treatment with milbemycin oxime provided some seasonal protection against T. callipaeda infestation in dogs from an endemic area of northern Italy [121,122].”
From Vector-borne helminths of dogs and humans in Europe (2013) · cites this paper as [122]
Cites
Nematode parasites of vertebrates: their development and transmission
Anderson, R. C. (2000) · CABI Publishing eBooks · doi:10.1079/9780851994215.0000 · Cited by 2,487 · see citing works
Nematode Parasites of Vertebrates. Their Development and Transmission
Weischer, B. (2000) · Journal of Phytopathology · doi:10.1111/j.1439-0434.2000.00560.x · Cited by 484 · see citing works
OTRANTO, D., LIA, R. P., CANTACESSI, C., TESTINI, G., TROCCOLI, A., SHEN, J. L., & WANG, Z. X. (2005) · Parasitology · doi:10.1017/s0031182005008395 · Cited by 125 · see citing works
Otranto, D., Ferroglio, E., Lia, R. P., Traversa, D., & Rossi, L. (2003) · Veterinary Parasitology · doi:10.1016/j.vetpar.2003.07.022 · Cited by 120 · see citing works
Self-citationDorchies, P., Chaudieu, G., Siméon, L., Cazalot, G., Cantacessi, C., & Otranto, D. (2007) · Veterinary Parasitology · doi:10.1016/j.vetpar.2007.08.005 · Cited by 86 · see citing works
Presence of Thelazia callipaeda Railliet & Henry, 1910, in Piedmont, Italy.
Rossi, L., & Bertaglia, P. P. (1991) · PubMed · Cited by 73 · see citing works
Self-citationBianciardi, P., & Otranto, D. (2005) · Veterinary Parasitology · doi:10.1016/j.vetpar.2004.12.020 · Cited by 55 · see citing works
Self-citationFirst case of Thelazia callipaeda infection in a dog in Germany
Hermosilla, C. R., Bauer, C. H., & Herrmann, B. (2004) · Veterinary Record · doi:10.1136/vr.154.18.568 · Cited by 42 · see citing works
Lia, R. P., Traversa, D., Agostini, A., & Otranto, D. (2004) · Veterinary Record · doi:10.1136/vr.154.5.143 · Cited by 38 · see citing works
First case of human Thelaziasis in Indonesia.
Kosin, E., Kosman, M. L., & Depary, A. A. (1989) · PubMed · Cited by 26 · see citing works
Canine ocular thelaziosis in Europe.
Chermette, R., Guillot, J., & Bussiéras, J. (2004) · PubMed · Cited by 20 · see citing works
Guerrero, J., McCall, J. W., & Genchi, C. (2002) · Macrocyclic lactones in antiparasitic therapy · doi:10.1079/9780851996172.0353 · Cited by 17 · see citing works
Morphological variability and degenerative evolution of human hepatic hydatid cysts.
Bortoletti, G., Cagetti, M., Gabriele, F., et al. (2002) · PubMed · Cited by 10 · see citing works
[Effect of certain agents on antigenic activity of Salmonella].
Duniavin, A. V., & Kazakov, K. S. (1974) · PubMed · Cited by 2 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Vector-borne helminths of dogs and humans in Europe
Otranto, D., Dantas-Torres, F., Brianti, E., Traversa, D., Petrić, D., Genchi, C., & Capelli, G. (2013) · Parasites & Vectors · doi:10.1186/1756-3305-6-16 · Cited by 336 · see citing works
First report of canine ocular thelaziosis by Thelazia callipaeda in Portugal
Vieira, L., Rodrigues, F. T., Costa, Á., Diz-Lopes, D., Machado, J., Coutinho, T., Tuna, J., Latrofa, M. S., Cardoso, L., & Otranto, D. (2012) · Parasites & Vectors · doi:10.1186/1756-3305-5-124 · Cited by 61 · see citing works
- Authors
- Ferroglio, E., Rossi, L., Tomio, E., Schenker, R., & Bianciardi, P.
- Affiliations
- University of Turin (IT)
- Novartis (Switzerland) (CH)
- Corresponding author
- Ferroglio, E.
- Venue
- Veterinary Parasitology
- Publisher
- Elsevier BV
- Published
- 2008-07
- Volume
- 154
- Issue
- 3-4
- Pages
- 351-353
- ISSN
- 0304-4017 (ISSN-L)
- OpenAlex
- W2083994194
- Cited by
- 35
- References
- 14
- Citations by year
- 2026: 1 · 2025: 4 · 2022: 3 · 2021: 4 · 2020: 4 · 2019: 2 · 2018: 1 · 2017: 1 · 2016: 2 · 2015: 2 · 2014: 3 · 2013: 3 · 2012: 4
- FWCI
- 0.20
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Veterinary Parasitology (publishedVersion)
- PubMed (publishedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Parasitic Diseases Research and Treatment
- Health Sciences › Veterinary › Small Animals › Helminth infection and control
- Life Sciences › Immunology and Microbiology › Parasitology › Parasites and Host Interactions
- Keywords
- milbemycin oxime, interceptors, Thelazia callipaeda, dogs, treatment efficacy, prophylaxis efficacy, ocular parasitic infection
- MeSH terms
- Animals, Anthelmintics, Dog Diseases, Dogs, Spirurida Infections, Macrolides
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
